Indoximod is an indolyl carboxylic acid. Indoximod has been used in trials studying the treatment of Glioma, Melanoma, Ependymoma, Gliosarcoma, and Lung Cancer, among others. Indoximod is a methylated tryptophan with immune checkpoint inhibitory activity. Indoximod inhibits the enzyme indoleamine 2,3-dioxygenase (IDO), which degrades the essential amino acid tryptophan, and may increase or maintain tryptophan levels important to T cell function. Tryptophan depletion is associated with immunosuppression involving T cell arrest and anergy. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include D-1-methyltryptophan and indoximodum. Its PubChem CID is 405012.
Indoximod
| CAS No | 110117-83-4 |
|---|---|
| Molecular Formula | C12H14N2O2 |
| Molecular Weight | 218.25 g/mol |
| Synonyms | (2R)-2-amino-3-(1-methylindol-3-yl)propanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Indoximod is an indolyl carboxylic acid. Indoximod has been used in trials studying the treatment of Glioma, Melanoma, Ependymoma, Gliosarcoma, and Lung Cancer, among others.
The listed CAS number is 110117-83-4.
The listed molecular formula is C12H14N2O2.
The listed molecular weight is 218.25 g/mol.
(2R)-2-amino-3-(1-methylindol-3-yl)propanoic acid.
The source lists D-1-methyltryptophan and indoximodum.